CCAT2 acts as competing endogenous RNA (ceRNA) or sponge via negatively targeting miR-424, providing a novel diagnostic marker and therapeutic target for EOC. (28550684)
user: 0
Pubmeds:
Login
For any questions and suggestions, write to us by mail: info@onco.io